Home»
Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy.
Accès à distance ? S'identifier sur le proxy UCLouvain
Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy.
Several statins are substrates for the multidrug resistance-associated protein 2 transporter, encoded by the ABCC2 gene. We analyzed in the Rotterdam Study whether the common polymorphisms -24C>T, 1249G>A and 3972C>T in the ABCC2 gene were associated with a dose decrease or switch to another cholesterol-lowering drug in simvastatin and atorvastatin users. These events could indicate an adverse effect or a too strong reduction in cholesterol level. We identified 1014 simvastatin and atorvastatin users during the period 1 January 1991 to 1 January 2010. Associations between genetic variation and the risk of these events were analyzed using Cox proportional hazards modelling. The ABCC2 -24C>T genotype (HR 1.32 95% CI 1.04-1.69) and the H12 haplotype versus the H2 haplotype (HR 1.49; 95% CI 1.06-2.09) were associated with these events in simvastatin users. A similar but not significant association was found in atorvastatin users. To conclude, genetic variation in the ABCC2 gene is associated with these events in simvastatin users.
Becker Matthijs L, Visser Loes E, van Schaik Ron HN, Hofman Albert, Uitterlinden André G, Stricker Bruno HCh, Common genetic variation in theABCB1gene is associated with the cholesterol-lowering effect of simvastatin in males, 10.2217/pgs.09.105
Rodrigues Alice C, Efflux and uptake transporters as determinants of statin response, 10.1517/17425251003713519
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study, 10.1056/nejmoa0801936
Cascorbi Ingolf, Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs, 10.1016/j.pharmthera.2006.04.009
Giacomini Kathleen M., Huang Shiew-Mei, Tweedie Donald J., Benet Leslie Z., Brouwer Kim L.R., Chu Xiaoyan, Dahlin Amber, Evers Raymond, Fischer Volker, Hillgren Kathleen M., Hoffmaster Keith A., Ishikawa Toshihisa, Keppler Dietrich, Kim Richard B., Lee Caroline A., Niemi Mikko, Polli Joseph W., Sugiyama Yuicchi, Swaan Peter W., Ware Joseph A., Wright Stephen H., Wah Yee Sook, Zamek-Gliszczynski Maciej J., Zhang Lei, Membrane transporters in drug development, 10.1038/nrd3028
Kivisto K. T., DISPOSITION OF ORAL AND INTRAVENOUS PRAVASTATIN IN MRP2-DEFICIENT TR- RATS, 10.1124/dmd.105.006262
Li J., Volpe D. A., Wang Y., Zhang W., Bode C., Owen A., Hidalgo I. J., Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin Drugs, 10.1124/dmd.111.038075
Laechelt S, Turrini E, Ruehmkorf A, Siegmund W, Cascorbi I, Haenisch S, Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function, 10.1038/tpj.2010.20
Hofman Albert, Breteler Monique M. B., van Duijn Cornelia M., Janssen Harry L. A., Krestin Gabriel P., Kuipers Ernst J., Stricker Bruno H. Ch., Tiemeier Henning, Uitterlinden André G., Vingerling Johannes R., Witteman Jacqueline C. M., The Rotterdam Study: 2010 objectives and design update, 10.1007/s10654-009-9386-z
Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HAP, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG, Spector TD, Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study, 10.1016/s0140-6736(08)60599-1
, , Gibbs Richard A., Belmont John W., Hardenbol Paul, Willis Thomas D., Yu Fuli, Yang Huanming, Ch'ang Lan-Yang, Huang Wei, Liu Bin, Shen Yan, Tam Paul Kwong-Hang, Tsui Lap-Chee, Waye Mary Miu Yee, Wong Jeffrey Tze-Fei, Zeng Changqing, Zhang Qingrun, Chee Mark S., Galver Luana M., Kruglyak Semyon, Murray Sarah S., Oliphant Arnold R., Montpetit Alexandre, Hudson Thomas J., Chagnon Fanny, Ferretti Vincent, Leboeuf Martin, Phillips Michael S., Verner Andrei, Kwok Pui-Yan, Duan Shenghui, Lind Denise L., Miller Raymond D., Rice John P., Saccone Nancy L., Taillon-Miller Patricia, Xiao Ming, Nakamura Yusuke, Sekine Akihiro, Sorimachi Koki, Tanaka Toshihiro, Tanaka Yoichi, Tsunoda Tatsuhiko, Yoshino Eiji, Bentley David R., Deloukas Panos, Hunt Sarah, Powell Don, Altshuler David, Gabriel Stacey B., Zhang Houcan, Zeng Changqing, Matsuda Ichiro, Fukushima Yoshimitsu, Macer Darryl R., Suda Eiko, Rotimi Charles N., Adebamowo Clement A., Aniagwu Toyin, Marshall Patricia A., Matthew Olayemi, Nkwodimmah Chibuzor, Royal Charmaine D. M., Leppert Mark F., Dixon Missy, Stein Lincoln D., Cunningham Fiona, Kanani Ardavan, Thorisson Gudmundur A., Chakravarti Aravinda, Chen Peter E., Cutler David J., Kashuk Carl S., Donnelly Peter, Marchini Jonathan, McVean Gilean A. T., Myers Simon R., Cardon Lon R., Abecasis Gonçalo R., Morris Andrew, Weir Bruce S., Mullikin James C., Sherry Stephen T., Feolo Michael, Altshuler David, Daly Mark J., Schaffner Stephen F., Qiu Renzong, Kent Alastair, Dunston Georgia M., Kato Kazuto, Niikawa Norio, Knoppers Bartha M., Foster Morris W., Clayton Ellen Wright, Wang Vivian Ota, Watkin Jessica, Gibbs Richard A., Belmont John W., Sodergren Erica, Weinstock George M., Wilson Richard K., Fulton Lucinda L., Rogers Jane, Birren Bruce W., Han Hua, Wang Hongguang, Godbout Martin, Wallenburg John C., L'Archevêque Paul, Bellemare Guy, Todani Kazuo, Fujita Takashi, Tanaka Satoshi, Holden Arthur L., Lai Eric H., Collins Francis S., Brooks Lisa D., McEwen Jean E., Guyer Mark S., Jordan Elke, Peterson Jane L., Spiegel Jack, Sung Lawrence M., Zacharia Lynn F., Kennedy Karen, Dunn Michael G., Seabrook Richard, Shillito Mark, Skene Barbara, Stewart John G., Valle (chair) David L., Clayton (co-chair) Ellen Wright, Jorde (co-chair) Lynn B., Belmont John W., Chakravarti Aravinda, Cho Mildred K., Duster Troy, Foster Morris W., Jasperse Marla, Knoppers Bartha M., Kwok Pui-Yan, Licinio Julio, Long Jeffrey C., Marshall Patricia A., Ossorio Pilar N., Wang Vivian Ota, Rotimi Charles N., Royal Charmaine D. M., Spallone Patricia, Terry Sharon F., Lander (chair) Eric S., Lai (co-chair) Eric H., Nickerson (co-chair) Deborah A., Abecasis Gonçalo R., Altshuler David, Bentley David R., Boehnke Michael, Cardon Lon R., Daly Mark J., Deloukas Panos, Douglas Julie A., Gabriel Stacey B., Hudson Richard R., Hudson Thomas J., Kruglyak Leonid, Kwok Pui-Yan, Nakamura Yusuke, Nussbaum Robert L., Royal Charmaine D. M., Schaffner Stephen F., Sherry Stephen T., Stein Lincoln D., Tanaka Toshihiro, , The International HapMap Project, 10.1038/nature02168
Fang Yue, van Meurs Joyce B.J., d'Alesio Arnold, Jhamai Mila, Zhao Hongyan, Rivadeneira Fernando, Hofman Albert, van Leeuwen Johannes P.T., Jehan Frédéric, Pols Huibert A.P., Uitterlinden André G., Promoter and 3′-Untranslated-Region Haplotypes in the Vitamin D Receptor Gene Predispose to Osteoporotic Fracture: The Rotterdam Study, 10.1086/497438
Stephens Matthew, Donnelly Peter, A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data, 10.1086/379378
Stephens Matthew, Smith Nicholas J., Donnelly Peter, A New Statistical Method for Haplotype Reconstruction from Population Data, 10.1086/319501
Cummins C, Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein, 10.1067/mcp.2002.128388
Wacher Vincent J., Silverman Jeffrey A., Zhang Yuanchao, Benet Leslie Z., Role of P-Glycoprotein and Cytochrome P450 3A in Limiting Oral Absorption of Peptides and Peptidomimetics†, 10.1021/js980082d
Chen C., Lin J., Smolarek T., Tremaine L., P-glycoprotein Has Differential Effects on the Disposition of Statin Acid and Lactone Forms in mdr1a/b Knockout and Wild-Type Mice, 10.1124/dmd.107.015677
Chen C., DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1, 10.1124/dmd.104.002477
Keskitalo JE, Kurkinen KJ, Neuvonen PJ, Niemi M, ABCB1 Haplotypes Differentially Affect the Pharmacokinetics of the Acid and Lactone Forms of Simvastatin and Atorvastatin, 10.1038/clpt.2008.25
FIEGENBAUM M, DASILVEIRA F, VANDERSAND C, VANDERSAND L, FERREIRA M, PIRES R, HUTZ M, The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment, 10.1016/j.clpt.2005.08.003
Donnelly L A, Doney A S F, Tavendale R, Lang C C, Pearson E R, Colhoun H M, McCarthy M I, Hattersley A T, Morris A D, Palmer C N A, Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study, 10.1038/clpt.2010.255
Bibliographic reference
Becker, M L ; Elens, Laure ; Visser, L E ; Hofman, A ; Uitterlinden, A G ; et. al. Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy.. In: The Pharmacogenomics Journal, Vol. 13, no.3, p. 251-256 (2011)